Skip to main content

Andre Pascal Kengne

Elected: 2020

Country (Nationality)

South Africa


Medical & Health Sciences


Prof Andre Pascal Kengne is a scientist and medical doctor with a speciality in internal medicine. He received his basic and specialist training from the School of Medicine of Yaounde 1 university in Cameroon. He then completed a PhD in Medicine with major concentration on cardiovascular epidemiology and prevention, from the School of Medicine and George Institute for Global Health at the University of Sydney, in Australia in 2009. He joined the South African Medical Research Council (SAMRC) in 2011 as the first Director of its Collaborative Research Programme on CVD and Metabolic Diseases, and was promoted in 2013 to lead the newly established and consolidated NCD Research Unit of the organization. He holds conjoint appointments as Professor at the Department of the Department of Medicine of the University of Cape Town, and Extraordinary Professor at the Department of Global Health of the Stellenbosch University, South Africa.

He is a senior fellow of the George Institute for Global Health (Australia), and the Julius Center for Health Sciences and Primary Care (Holland). His areas of research include chronic diseases epidemiology and prevention in developing countries, decision making in diabetes and cardiovascular diseases. He is the developer of the ADVANCE risk model to estimate cardiovascular disease risk in people with diabetes, and pioneer of task-shifting as an approach to improve access to prevention and control of non-communicable disease (NCD) in resource-constrained setting. He is co-author of over 550 peer-reviewed articles, many book chapters and monographs; and board member of several journals, including the leading International Journal of Epidemiology. He is member of several professional bodies, and leading expert groups, and has received several distinctions as a researcher, the most recent being the the Sir Alberti Award for Excellent in research on diabetes in Africa, awarded in 2017.